Search
Selected: All

Modified human interferon-β polypeptides

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Modified vaccinia virus ankara for the vaccination of neonates

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Modulation of animal cellular responses with compositions contai

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Murine interferon-α

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Murine interferon-&agr;

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Mutant human interferons

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Mutant interferon α protein and use thereof

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Muteins of IFN-.beta.

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

N-terminally chemically modified protein compositions and method

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel hybrid interferon species

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Novel polynucleotide analogs, methods for inhibiting nucleic aci

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Oncostatin M and novel compositions having anti-neoplastic activ

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Optimal compositions and methods thereof for treating HCV...

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Oral drug delivery compositions and methods

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Orally-administered interferon-tau compositions and methods

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Orally-administered interferon-tau compositions and methods

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Orally-administered interferon-TAU compositions and methods

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Orally-administrable therapeutic and/or prophylactic agent...

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Pharmaceutical administration systems containing a mixture of im

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Pharmaceutical composition for treatment of sudden deafness

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.